nodes	percent_of_prediction	percent_of_DWPC	metapath
Neostigmine—BCHE—malignant glioma	0.939	1	CbGaD
Neostigmine—Demecarium—BCHE—malignant glioma	0.00413	0.376	CrCbGaD
Neostigmine—Pyridostigmine—BCHE—malignant glioma	0.00266	0.242	CrCbGaD
Neostigmine—Edrophonium—BCHE—malignant glioma	0.00217	0.198	CrCbGaD
Neostigmine—Rivastigmine—BCHE—malignant glioma	0.00202	0.184	CrCbGaD
Neostigmine—Abnormal behaviour—Temozolomide—malignant glioma	0.00179	0.105	CcSEcCtD
Neostigmine—ACHE—Synthesis, secretion, and deacylation of Ghrelin—BCHE—malignant glioma	0.00108	0.0374	CbGpPWpGaD
Neostigmine—ACHE—Synthesis of PC—BCHE—malignant glioma	0.000988	0.0342	CbGpPWpGaD
Neostigmine—Urinary incontinence—Carmustine—malignant glioma	0.000667	0.0391	CcSEcCtD
Neostigmine—Urinary incontinence—Temozolomide—malignant glioma	0.000645	0.0378	CcSEcCtD
Neostigmine—Coma—Carmustine—malignant glioma	0.000631	0.037	CcSEcCtD
Neostigmine—ACHE—Monoamine Transport—SLC6A3—malignant glioma	0.000612	0.0212	CbGpPWpGaD
Neostigmine—BCHE—Irinotecan Pathway—APC—malignant glioma	0.000611	0.0211	CbGpPWpGaD
Neostigmine—ACHE—ATF-2 transcription factor network—NF1—malignant glioma	0.000566	0.0196	CbGpPWpGaD
Neostigmine—ACHE—telencephalon—malignant glioma	0.000478	0.108	CbGeAlD
Neostigmine—ABCB1—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.000464	0.016	CbGpPWpGaD
Neostigmine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.000442	0.0153	CbGpPWpGaD
Neostigmine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PIM1—malignant glioma	0.000413	0.0143	CbGpPWpGaD
Neostigmine—Sweating increased—Temozolomide—malignant glioma	0.000408	0.0239	CcSEcCtD
Neostigmine—Pollakiuria—Temozolomide—malignant glioma	0.000387	0.0227	CcSEcCtD
Neostigmine—ACHE—medulla oblongata—malignant glioma	0.000376	0.0849	CbGeAlD
Neostigmine—ACHE—midbrain—malignant glioma	0.000343	0.0776	CbGeAlD
Neostigmine—Connective tissue disorder—Carmustine—malignant glioma	0.000341	0.02	CcSEcCtD
Neostigmine—ACHE—spinal cord—malignant glioma	0.000335	0.0757	CbGeAlD
Neostigmine—Urinary tract disorder—Temozolomide—malignant glioma	0.000331	0.0194	CcSEcCtD
Neostigmine—Connective tissue disorder—Temozolomide—malignant glioma	0.00033	0.0193	CcSEcCtD
Neostigmine—Urethral disorder—Temozolomide—malignant glioma	0.000329	0.0192	CcSEcCtD
Neostigmine—Flushing—Carmustine—malignant glioma	0.000322	0.0189	CcSEcCtD
Neostigmine—Flushing—Temozolomide—malignant glioma	0.000311	0.0182	CcSEcCtD
Neostigmine—Arrhythmia—Carmustine—malignant glioma	0.00031	0.0182	CcSEcCtD
Neostigmine—Mental disorder—Carmustine—malignant glioma	0.000304	0.0178	CcSEcCtD
Neostigmine—Mediastinal disorder—Temozolomide—malignant glioma	0.000302	0.0177	CcSEcCtD
Neostigmine—ACHE—Peptide hormone metabolism—BCHE—malignant glioma	0.000298	0.0103	CbGpPWpGaD
Neostigmine—Mental disorder—Temozolomide—malignant glioma	0.000294	0.0172	CcSEcCtD
Neostigmine—ACHE—ATF-2 transcription factor network—HES1—malignant glioma	0.000294	0.0102	CbGpPWpGaD
Neostigmine—ACHE—Glycerophospholipid biosynthesis—BCHE—malignant glioma	0.00029	0.01	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.000286	0.00991	CbGpPWpGaD
Neostigmine—ACHE—ATF-2 transcription factor network—PDGFRA—malignant glioma	0.000279	0.00967	CbGpPWpGaD
Neostigmine—Agitation—Carmustine—malignant glioma	0.000278	0.0163	CcSEcCtD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—NDRG1—malignant glioma	0.000277	0.00956	CbGpPWpGaD
Neostigmine—Agitation—Temozolomide—malignant glioma	0.000268	0.0157	CcSEcCtD
Neostigmine—ACHE—cerebellum—malignant glioma	0.000266	0.06	CbGeAlD
Neostigmine—BCHE—brainstem—malignant glioma	0.000265	0.0598	CbGeAlD
Neostigmine—Convulsion—Carmustine—malignant glioma	0.000262	0.0153	CcSEcCtD
Neostigmine—Convulsion—Temozolomide—malignant glioma	0.000253	0.0148	CcSEcCtD
Neostigmine—ACHE—Monoamine Transport—IL1B—malignant glioma	0.00025	0.00864	CbGpPWpGaD
Neostigmine—Arthralgia—Temozolomide—malignant glioma	0.000249	0.0146	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000247	0.0145	CcSEcCtD
Neostigmine—Dry mouth—Temozolomide—malignant glioma	0.000243	0.0142	CcSEcCtD
Neostigmine—Tachycardia—Carmustine—malignant glioma	0.000241	0.0141	CcSEcCtD
Neostigmine—ABCB1—Allograft Rejection—GDNF—malignant glioma	0.000239	0.00828	CbGpPWpGaD
Neostigmine—Anaphylactic shock—Temozolomide—malignant glioma	0.000238	0.014	CcSEcCtD
Neostigmine—BCHE—telencephalon—malignant glioma	0.000235	0.0531	CbGeAlD
Neostigmine—Nervous system disorder—Temozolomide—malignant glioma	0.000234	0.0137	CcSEcCtD
Neostigmine—Skin disorder—Temozolomide—malignant glioma	0.000231	0.0136	CcSEcCtD
Neostigmine—ABCB1—blood vessel—malignant glioma	0.000231	0.0522	CbGeAlD
Neostigmine—Hypotension—Carmustine—malignant glioma	0.00023	0.0135	CcSEcCtD
Neostigmine—Hyperhidrosis—Temozolomide—malignant glioma	0.00023	0.0135	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000225	0.0132	CcSEcCtD
Neostigmine—Insomnia—Carmustine—malignant glioma	0.000223	0.0131	CcSEcCtD
Neostigmine—Dyspnoea—Carmustine—malignant glioma	0.00022	0.0129	CcSEcCtD
Neostigmine—Somnolence—Carmustine—malignant glioma	0.000219	0.0128	CcSEcCtD
Neostigmine—ABCB1—Allograft Rejection—IL12A—malignant glioma	0.000219	0.00758	CbGpPWpGaD
Neostigmine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000217	0.0127	CcSEcCtD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.000217	0.00751	CbGpPWpGaD
Neostigmine—ACHE—brain—malignant glioma	0.000216	0.0487	CbGeAlD
Neostigmine—Insomnia—Temozolomide—malignant glioma	0.000216	0.0126	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Carmustine—malignant glioma	0.000213	0.0125	CcSEcCtD
Neostigmine—Dyspnoea—Temozolomide—malignant glioma	0.000212	0.0124	CcSEcCtD
Neostigmine—Somnolence—Temozolomide—malignant glioma	0.000212	0.0124	CcSEcCtD
Neostigmine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—malignant glioma	0.000206	0.00712	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.000206	0.00712	CbGpPWpGaD
Neostigmine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000206	0.012	CcSEcCtD
Neostigmine—ACHE—Phospholipid metabolism—BCHE—malignant glioma	0.000202	0.007	CbGpPWpGaD
Neostigmine—Gastrointestinal pain—Carmustine—malignant glioma	0.000202	0.0118	CcSEcCtD
Neostigmine—Abdominal pain—Carmustine—malignant glioma	0.000195	0.0114	CcSEcCtD
Neostigmine—Gastrointestinal pain—Temozolomide—malignant glioma	0.000195	0.0114	CcSEcCtD
Neostigmine—ACHE—ATF-2 transcription factor network—MMP2—malignant glioma	0.000192	0.00664	CbGpPWpGaD
Neostigmine—Urticaria—Temozolomide—malignant glioma	0.000189	0.0111	CcSEcCtD
Neostigmine—Abdominal pain—Temozolomide—malignant glioma	0.000188	0.011	CcSEcCtD
Neostigmine—BCHE—medulla oblongata—malignant glioma	0.000185	0.0417	CbGeAlD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.000183	0.00634	CbGpPWpGaD
Neostigmine—Hypersensitivity—Carmustine—malignant glioma	0.000182	0.0106	CcSEcCtD
Neostigmine—ACHE—Monoamine Transport—TNF—malignant glioma	0.000181	0.00627	CbGpPWpGaD
Neostigmine—Asthenia—Carmustine—malignant glioma	0.000177	0.0104	CcSEcCtD
Neostigmine—Hypersensitivity—Temozolomide—malignant glioma	0.000176	0.0103	CcSEcCtD
Neostigmine—ACHE—ATF-2 transcription factor network—BCL2—malignant glioma	0.000173	0.00599	CbGpPWpGaD
Neostigmine—ACHE—ATF-2 transcription factor network—IFNG—malignant glioma	0.000172	0.00594	CbGpPWpGaD
Neostigmine—Asthenia—Temozolomide—malignant glioma	0.000171	0.01	CcSEcCtD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—TFRC—malignant glioma	0.000171	0.00591	CbGpPWpGaD
Neostigmine—BCHE—midbrain—malignant glioma	0.000169	0.0381	CbGeAlD
Neostigmine—Diarrhoea—Carmustine—malignant glioma	0.000169	0.00988	CcSEcCtD
Neostigmine—Pruritus—Temozolomide—malignant glioma	0.000169	0.00987	CcSEcCtD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.000168	0.0058	CbGpPWpGaD
Neostigmine—BCHE—spinal cord—malignant glioma	0.000165	0.0372	CbGeAlD
Neostigmine—Dizziness—Carmustine—malignant glioma	0.000163	0.00955	CcSEcCtD
Neostigmine—Diarrhoea—Temozolomide—malignant glioma	0.000163	0.00955	CcSEcCtD
Neostigmine—ABCB1—Allograft Rejection—HLA-C—malignant glioma	0.000162	0.00559	CbGpPWpGaD
Neostigmine—ACHE—ATF-2 transcription factor network—CXCL8—malignant glioma	0.00016	0.00552	CbGpPWpGaD
Neostigmine—Dizziness—Temozolomide—malignant glioma	0.000158	0.00923	CcSEcCtD
Neostigmine—Vomiting—Carmustine—malignant glioma	0.000157	0.00918	CcSEcCtD
Neostigmine—Rash—Carmustine—malignant glioma	0.000155	0.0091	CcSEcCtD
Neostigmine—Dermatitis—Carmustine—malignant glioma	0.000155	0.00909	CcSEcCtD
Neostigmine—Headache—Carmustine—malignant glioma	0.000154	0.00904	CcSEcCtD
Neostigmine—Vomiting—Temozolomide—malignant glioma	0.000151	0.00887	CcSEcCtD
Neostigmine—ACHE—Transmission across Chemical Synapses—BCHE—malignant glioma	0.00015	0.0052	CbGpPWpGaD
Neostigmine—Rash—Temozolomide—malignant glioma	0.00015	0.0088	CcSEcCtD
Neostigmine—Dermatitis—Temozolomide—malignant glioma	0.00015	0.00879	CcSEcCtD
Neostigmine—Headache—Temozolomide—malignant glioma	0.000149	0.00874	CcSEcCtD
Neostigmine—Nausea—Carmustine—malignant glioma	0.000146	0.00858	CcSEcCtD
Neostigmine—Nausea—Temozolomide—malignant glioma	0.000142	0.00829	CcSEcCtD
Neostigmine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000141	0.00489	CbGpPWpGaD
Neostigmine—ACHE—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000141	0.00489	CbGpPWpGaD
Neostigmine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—malignant glioma	0.000141	0.00488	CbGpPWpGaD
Neostigmine—ABCB1—embryo—malignant glioma	0.000138	0.0311	CbGeAlD
Neostigmine—ABCB1—Allograft Rejection—IL12B—malignant glioma	0.000138	0.00476	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—RTEL1—malignant glioma	0.000136	0.00472	CbGpPWpGaD
Neostigmine—BCHE—central nervous system—malignant glioma	0.000134	0.0302	CbGeAlD
Neostigmine—BCHE—cerebellum—malignant glioma	0.000131	0.0295	CbGeAlD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.00013	0.00451	CbGpPWpGaD
Neostigmine—BCHE—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000126	0.00436	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.000125	0.00431	CbGpPWpGaD
Neostigmine—ABCB1—retina—malignant glioma	0.000122	0.0275	CbGeAlD
Neostigmine—BCHE—Metabolism—RTEL1—malignant glioma	0.000122	0.00421	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.000121	0.00419	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.00012	0.00416	CbGpPWpGaD
Neostigmine—ACHE—Neuronal System—BCHE—malignant glioma	0.000115	0.00398	CbGpPWpGaD
Neostigmine—ABCB1—telencephalon—malignant glioma	0.000112	0.0253	CbGeAlD
Neostigmine—ACHE—Metabolism of proteins—XBP1—malignant glioma	0.00011	0.0038	CbGpPWpGaD
Neostigmine—ACHE—Phospholipid metabolism—PIK3CG—malignant glioma	0.00011	0.0038	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.000109	0.00378	CbGpPWpGaD
Neostigmine—ACHE—Neuronal System—SLC6A3—malignant glioma	0.000108	0.00374	CbGpPWpGaD
Neostigmine—BCHE—brain—malignant glioma	0.000106	0.024	CbGeAlD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—TERT—malignant glioma	0.000102	0.00354	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—XBP1—malignant glioma	9.81e-05	0.00339	CbGpPWpGaD
Neostigmine—BCHE—Phospholipid metabolism—PIK3CG—malignant glioma	9.8e-05	0.00339	CbGpPWpGaD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—HIF1A—malignant glioma	9.79e-05	0.00339	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	9.76e-05	0.00337	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	9.75e-05	0.00337	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—SLC6A3—malignant glioma	9.66e-05	0.00334	CbGpPWpGaD
Neostigmine—ACHE—Phospholipid metabolism—PIK3CD—malignant glioma	9.65e-05	0.00334	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—PDGFRA—malignant glioma	9.63e-05	0.00333	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—HLA-B—malignant glioma	9.57e-05	0.00331	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	9.45e-05	0.00327	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	9.43e-05	0.00326	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	8.96e-05	0.0031	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—HLA-A—malignant glioma	8.86e-05	0.00307	CbGpPWpGaD
Neostigmine—ABCB1—medulla oblongata—malignant glioma	8.8e-05	0.0199	CbGeAlD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	8.74e-05	0.00302	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	8.7e-05	0.00301	CbGpPWpGaD
Neostigmine—BCHE—Phospholipid metabolism—PIK3CD—malignant glioma	8.61e-05	0.00298	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	8.47e-05	0.00293	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	8.42e-05	0.00291	CbGpPWpGaD
Neostigmine—ACHE—Phospholipid metabolism—PIK3CB—malignant glioma	8.41e-05	0.00291	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	8.37e-05	0.00289	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—SPHK1—malignant glioma	8.15e-05	0.00282	CbGpPWpGaD
Neostigmine—ABCB1—midbrain—malignant glioma	8.04e-05	0.0182	CbGeAlD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	7.98e-05	0.00276	CbGpPWpGaD
Neostigmine—ABCB1—spinal cord—malignant glioma	7.85e-05	0.0177	CbGeAlD
Neostigmine—ACHE—Metabolism—COX8A—malignant glioma	7.84e-05	0.00271	CbGpPWpGaD
Neostigmine—ACHE—Transmission across Chemical Synapses—BRAF—malignant glioma	7.67e-05	0.00265	CbGpPWpGaD
Neostigmine—BCHE—Phospholipid metabolism—PIK3CB—malignant glioma	7.51e-05	0.0026	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—CD80—malignant glioma	7.48e-05	0.00259	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	7.3e-05	0.00253	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—COX8A—malignant glioma	7.28e-05	0.00252	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—SPHK1—malignant glioma	7.27e-05	0.00252	CbGpPWpGaD
Neostigmine—ACHE—Phospholipid metabolism—PTEN—malignant glioma	7.27e-05	0.00251	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	7.13e-05	0.00246	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	7e-05	0.00242	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—COX8A—malignant glioma	6.99e-05	0.00242	CbGpPWpGaD
Neostigmine—BCHE—Transmission across Chemical Synapses—BRAF—malignant glioma	6.84e-05	0.00237	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	6.77e-05	0.00234	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	6.67e-05	0.00231	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ASMT—malignant glioma	6.66e-05	0.0023	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—FTH1—malignant glioma	6.66e-05	0.0023	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	6.64e-05	0.0023	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	6.57e-05	0.00227	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	6.51e-05	0.00225	CbGpPWpGaD
Neostigmine—BCHE—Phospholipid metabolism—PTEN—malignant glioma	6.49e-05	0.00224	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	6.43e-05	0.00222	CbGpPWpGaD
Neostigmine—ACHE—Transmission across Chemical Synapses—MDM2—malignant glioma	6.43e-05	0.00222	CbGpPWpGaD
Neostigmine—ACHE—Transmission across Chemical Synapses—RAF1—malignant glioma	6.4e-05	0.00222	CbGpPWpGaD
Neostigmine—ABCB1—central nervous system—malignant glioma	6.37e-05	0.0144	CbGeAlD
Neostigmine—ACHE—Metabolism—BCAN—malignant glioma	6.26e-05	0.00217	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	6.25e-05	0.00216	CbGpPWpGaD
Neostigmine—ABCB1—cerebellum—malignant glioma	6.22e-05	0.0141	CbGeAlD
Neostigmine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—malignant glioma	6.02e-05	0.00208	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	5.97e-05	0.00206	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ASMT—malignant glioma	5.94e-05	0.00206	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—RTEL1—malignant glioma	5.94e-05	0.00205	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—IFNG—malignant glioma	5.91e-05	0.00205	CbGpPWpGaD
Neostigmine—ACHE—Neuronal System—BRAF—malignant glioma	5.88e-05	0.00203	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	5.82e-05	0.00201	CbGpPWpGaD
Neostigmine—BCHE—Transmission across Chemical Synapses—MDM2—malignant glioma	5.73e-05	0.00198	CbGpPWpGaD
Neostigmine—BCHE—Transmission across Chemical Synapses—RAF1—malignant glioma	5.71e-05	0.00198	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	5.68e-05	0.00196	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—APOD—malignant glioma	5.66e-05	0.00196	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—BCHE—malignant glioma	5.63e-05	0.00195	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	5.61e-05	0.00194	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—BCAN—malignant glioma	5.59e-05	0.00193	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—FBXW7—malignant glioma	5.54e-05	0.00191	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—CXCL8—malignant glioma	5.5e-05	0.0019	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	5.28e-05	0.00183	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—IL1B—malignant glioma	5.28e-05	0.00182	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—CASP3—malignant glioma	5.26e-05	0.00182	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—IL2—malignant glioma	5.26e-05	0.00182	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—BRAF—malignant glioma	5.24e-05	0.00181	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	5.23e-05	0.00181	CbGpPWpGaD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—malignant glioma	5.16e-05	0.00178	CbGpPWpGaD
Neostigmine—ACHE—Phospholipid metabolism—PIK3CA—malignant glioma	5.13e-05	0.00177	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	5.06e-05	0.00175	CbGpPWpGaD
Neostigmine—ABCB1—brain—malignant glioma	5.05e-05	0.0114	CbGeAlD
Neostigmine—ACHE—Metabolism—IDH2—malignant glioma	5.05e-05	0.00175	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—FBXW7—malignant glioma	4.94e-05	0.00171	CbGpPWpGaD
Neostigmine—ACHE—Neuronal System—MDM2—malignant glioma	4.92e-05	0.0017	CbGpPWpGaD
Neostigmine—ACHE—Neuronal System—RAF1—malignant glioma	4.91e-05	0.0017	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	4.76e-05	0.00165	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	4.75e-05	0.00164	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYP2B6—malignant glioma	4.75e-05	0.00164	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	4.66e-05	0.00161	CbGpPWpGaD
Neostigmine—BCHE—Phospholipid metabolism—PIK3CA—malignant glioma	4.58e-05	0.00158	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	4.56e-05	0.00158	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—IDH2—malignant glioma	4.5e-05	0.00156	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—VEGFA—malignant glioma	4.47e-05	0.00154	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—MDM2—malignant glioma	4.39e-05	0.00152	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—RAF1—malignant glioma	4.38e-05	0.00151	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—IDH1—malignant glioma	4.34e-05	0.0015	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	4.34e-05	0.0015	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	4.3e-05	0.00149	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	4.25e-05	0.00147	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	4.25e-05	0.00147	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP2B6—malignant glioma	4.24e-05	0.00146	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—SPHK1—malignant glioma	4.2e-05	0.00145	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYP2C18—malignant glioma	4.12e-05	0.00142	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	3.95e-05	0.00137	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.88e-05	0.00134	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—IDH1—malignant glioma	3.87e-05	0.00134	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—TNF—malignant glioma	3.83e-05	0.00132	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	3.83e-05	0.00132	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	3.81e-05	0.00132	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—SPHK1—malignant glioma	3.75e-05	0.0013	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	3.69e-05	0.00127	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP2C18—malignant glioma	3.67e-05	0.00127	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	3.64e-05	0.00126	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.54e-05	0.00122	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.46e-05	0.0012	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.41e-05	0.00118	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—COX8A—malignant glioma	3.41e-05	0.00118	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GSTT1—malignant glioma	3.33e-05	0.00115	CbGpPWpGaD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	3.29e-05	0.00114	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	3.23e-05	0.00112	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—F2—malignant glioma	3.19e-05	0.0011	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.15e-05	0.00109	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PTGS1—malignant glioma	3.12e-05	0.00108	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.11e-05	0.00107	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	3.1e-05	0.00107	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.04e-05	0.00105	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GSTT1—malignant glioma	2.97e-05	0.00103	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	2.95e-05	0.00102	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	2.9e-05	0.001	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—BCHE—malignant glioma	2.9e-05	0.001	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ASMT—malignant glioma	2.9e-05	0.001	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	2.9e-05	0.001	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	2.89e-05	0.001	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—SLC5A5—malignant glioma	2.86e-05	0.000991	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	2.86e-05	0.00099	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—F2—malignant glioma	2.85e-05	0.000985	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	2.8e-05	0.000968	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PTGS1—malignant glioma	2.78e-05	0.000962	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.77e-05	0.000959	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—BCAN—malignant glioma	2.73e-05	0.000943	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.71e-05	0.000937	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—MMP2—malignant glioma	2.71e-05	0.000936	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.68e-05	0.000928	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	2.66e-05	0.000921	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	2.6e-05	0.000898	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—SLC5A5—malignant glioma	2.56e-05	0.000884	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	2.53e-05	0.000876	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	2.44e-05	0.000844	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.42e-05	0.000836	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—MMP2—malignant glioma	2.41e-05	0.000835	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.39e-05	0.000828	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.34e-05	0.00081	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GSTP1—malignant glioma	2.31e-05	0.000798	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—CXCL8—malignant glioma	2.25e-05	0.000778	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CAT—malignant glioma	2.25e-05	0.000777	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	2.2e-05	0.000762	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—IDH2—malignant glioma	2.2e-05	0.00076	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—NCOR1—malignant glioma	2.12e-05	0.000733	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.09e-05	0.000722	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP2B6—malignant glioma	2.07e-05	0.000715	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GSTP1—malignant glioma	2.06e-05	0.000712	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	2.03e-05	0.000701	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—CXCL8—malignant glioma	2.01e-05	0.000694	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CAT—malignant glioma	2e-05	0.000693	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	1.98e-05	0.000686	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—NCOR1—malignant glioma	1.89e-05	0.000654	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—IDH1—malignant glioma	1.89e-05	0.000654	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	1.89e-05	0.000653	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	1.87e-05	0.000648	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SPHK1—malignant glioma	1.83e-05	0.000633	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP2C18—malignant glioma	1.79e-05	0.00062	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CAV1—malignant glioma	1.73e-05	0.000598	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	1.72e-05	0.000595	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	1.67e-05	0.000576	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.65e-05	0.000571	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3CG—malignant glioma	1.57e-05	0.000545	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CAV1—malignant glioma	1.54e-05	0.000533	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PPARG—malignant glioma	1.52e-05	0.000526	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.47e-05	0.00051	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTT1—malignant glioma	1.45e-05	0.000501	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	1.41e-05	0.000486	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3CG—malignant glioma	1.4e-05	0.000486	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3CD—malignant glioma	1.38e-05	0.000479	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PTGS1—malignant glioma	1.36e-05	0.00047	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PPARG—malignant glioma	1.36e-05	0.000469	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—BCHE—malignant glioma	1.26e-05	0.000437	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SLC5A5—malignant glioma	1.25e-05	0.000431	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3CD—malignant glioma	1.23e-05	0.000427	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3CB—malignant glioma	1.21e-05	0.000417	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PTGS2—malignant glioma	1.2e-05	0.000413	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	1.15e-05	0.000397	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3CB—malignant glioma	1.08e-05	0.000372	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PTGS2—malignant glioma	1.07e-05	0.000369	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PTEN—malignant glioma	1.04e-05	0.000361	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTP1—malignant glioma	1e-05	0.000347	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CAT—malignant glioma	9.77e-06	0.000338	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PTEN—malignant glioma	9.3e-06	0.000322	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NCOR1—malignant glioma	9.23e-06	0.000319	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CAV1—malignant glioma	7.52e-06	0.00026	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3CA—malignant glioma	7.35e-06	0.000254	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3CG—malignant glioma	6.85e-06	0.000237	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PPARG—malignant glioma	6.61e-06	0.000229	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3CA—malignant glioma	6.56e-06	0.000227	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3CD—malignant glioma	6.02e-06	0.000208	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—AKT1—malignant glioma	6.01e-06	0.000208	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—AKT1—malignant glioma	5.36e-06	0.000185	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3CB—malignant glioma	5.25e-06	0.000182	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PTGS2—malignant glioma	5.2e-06	0.00018	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PTEN—malignant glioma	4.54e-06	0.000157	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3CA—malignant glioma	3.2e-06	0.000111	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—AKT1—malignant glioma	2.62e-06	9.04e-05	CbGpPWpGaD
